Document is current
Any future updates will be listed below
-
Authors
Udeshi, Namrata D. http://orcid.org/0000-0001-5312-1402
Mani, Deepak C.
Satpathy, Shankha http://orcid.org/0000-0002-6040-4854
Fereshetian, Shaunt
Gasser, Jessica A.
Svinkina, Tanya
Olive, Meagan E.
Ebert, Benjamin L. http://orcid.org/0000-0003-0197-5451
Mertins, Philipp http://orcid.org/0000-0002-2245-528X
Carr, Steven A. http://orcid.org/0000-0002-7203-4299
- License Information
-
More Information
Article History
Received: 14 March 2019
Accepted: 19 December 2019
First Online: 17 January 2020
Competing interests
: B.L.E. has received research funding from Celgene and Deerfield. He has received consulting fees from GRAIL, and he serves on the scientific advisory boards for Skyhawk Therapeutics and Exo Therapeutics. S.A.C. has received research funding from Celgene. He has received consulting fees from Pfizer and Biogen, and he serves on the scientific advisory boards of Kymera, Seer and PTM BioLabs. The other authors declare no competing interests.
